Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Bioio LLC
Profile last edited on: 6/12/2020      CAGE: 7ZZJ2      UEI: NCX4S2YKK6A8

Business Identifier: Drug target identification
Year Founded
2017
First Award
2019
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

36 Berkshire Drive
Saint Louis, MO 63117
   (314) 541-1564
   N/A
   N/A
Location: Single
Congr. District: 02
County: St. Louis

Public Profile

Involving personnel affiliated with Washington University, Bioio LLC offers drug target identification using CRISPRi/a screening. The approach is effective at mechanism of action target identification and can also predict alternative targets for a disease of interest that the drug is intended to treat as well as the drug's side-effect/off-targets. The first area of focus for this STTR funded project involves Novel Insulin-Sensitizing NASH/Diabetes Drugs,

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
1
Conversion Rate
50.00%
Phase I Dollars
$448,272
Phase II Dollars
$1,492,578
Total Awarded
$1,940,850

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 2 NIH $1,716,395
Project Title: Novel Insulin-Sensitizing NASH/Diabetes Drugs
2020 1 NIH $224,455
Project Title: Drug Target Identification Using Crispri/A Screening

Key People / Management

  Timothy R Peterson -- Founder and CEO

  Timothy R Peterson

Company News

There are no news available.